HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rolf Buslei Selected Research

Craniopharyngioma (Craniopharyngiomas)

1/2018Characterization of the murine orthotopic adamantinomatous craniopharyngioma PDX model by MRI in correlation with histology.
11/2017Expression of SRY-related HMG Box Transcription Factors (Sox) 2 and 9 in Craniopharyngioma Subtypes and Surrounding Brain Tissue.
12/2016Drug priming enhances radiosensitivity of adamantinomatous craniopharyngioma via downregulation of survivin.
1/2016EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cysts.
10/2015BRAF V600E analysis for the differentiation of papillary craniopharyngiomas and Rathke's cleft cysts.
1/2014Tight junction protein claudin-1 is differentially expressed in craniopharyngioma subtypes and indicates invasive tumor growth.
2/2012Results after treatment of craniopharyngiomas: further experiences with 73 patients since 1997.
7/2011EGFR signaling regulates tumor cell migration in craniopharyngiomas.
9/2010Hormone receptor expression in craniopharyngiomas: a clinicopathological correlation.
5/2010Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rolf Buslei Research Topics

Disease

34Neoplasms (Cancer)
10/2020 - 04/2005
15Craniopharyngioma (Craniopharyngiomas)
01/2018 - 06/2005
7Pituitary Neoplasms (Pituitary Adenoma)
01/2021 - 06/2005
7Glioma (Gliomas)
06/2007 - 04/2005
6Adenoma (Adenomas)
12/2021 - 01/2007
5Glioblastoma (Glioblastoma Multiforme)
05/2016 - 05/2006
4Central Nervous System Cysts (Suprasellar Cyst)
01/2016 - 06/2005
3Brain Neoplasms (Brain Tumor)
01/2015 - 10/2004
2Cysts
01/2018 - 06/2005
2Hypophysitis
11/2017 - 01/2007
2Meningioma (Meningiomas)
07/2014 - 03/2010
1Carcinoma (Carcinomatosis)
01/2020
1Lymphoma (Lymphomas)
12/2018
1Astrocytoma (Pilocytic Astrocytoma)
01/2018
1Rhabdoid Tumor (Rhabdoid Tumors)
01/2018
1Carcinogenesis
01/2018
1Autoimmune Hypophysitis
11/2017
1Fibrosis (Cirrhosis)
11/2017
1Autoimmune Pancreatitis
05/2017
1Horner Syndrome (Horner's Syndrome)
05/2017
1Oxyphilic Adenoma (Oncocytoma)
04/2017
1Inborn Genetic Diseases (Disease, Hereditary)
01/2016
1Hamartoma
01/2016
1Nervous System Neoplasms (Neoplasms, Nervous System)
03/2015
1Nerve Sheath Neoplasms (Nerve Sheath Neoplasm)
07/2014
1Acromegaly
10/2013
1Brain Injuries (Brain Injury)
07/2013
1Disease Progression
02/2012

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
10/2020 - 05/2005
5Adrenocorticotropic Hormone (ACTH)FDA Link
12/2021 - 01/2007
5Pharmaceutical PreparationsIBA
01/2018 - 05/2006
5beta CateninIBA
05/2010 - 06/2005
4Hormones (Hormone)IBA
12/2021 - 09/2010
4Protons (Proton)IBA
04/2007 - 10/2004
4Histone Deacetylases (Histone Deacetylase)IBA
08/2006 - 05/2005
3HMGB1 Protein (HMG1)IBA
03/2016 - 03/2014
3CateninsIBA
01/2015 - 07/2011
3VorinostatFDA Link
08/2006 - 05/2005
2Transcription Factors (Transcription Factor)IBA
12/2021 - 11/2018
2EpitopesIBA
12/2018 - 10/2015
2AntigensIBA
04/2017 - 07/2014
2ErbB Receptors (EGF Receptor)IBA
12/2016 - 07/2011
2CalreticulinIBA
03/2016 - 03/2016
2Progesterone Receptors (Progesterone Receptor)IBA
07/2014 - 09/2010
2AntibodiesIBA
07/2014 - 03/2010
2Claudin-1IBA
07/2014 - 01/2014
2Small Interfering RNA (siRNA)IBA
01/2014 - 07/2009
2fascinIBA
07/2011 - 05/2010
2N-acetylaspartate (N-acetyl aspartate)IBA
04/2007 - 10/2004
2CreatineIBA
04/2007 - 10/2004
2Choline (Choline Chloride)IBA
04/2007 - 10/2004
2entinostat (MS 275)IBA
08/2006 - 05/2006
2benzamideIBA
08/2006 - 05/2006
2ChromatinIBA
08/2006 - 05/2005
2Histone Deacetylase InhibitorsIBA
07/2006 - 05/2006
2enhanced green fluorescent proteinIBA
05/2006 - 04/2005
1ProlactinIBA
12/2021
1Temozolomide (Temodar)FDA LinkGeneric
01/2020
1AutoantigensIBA
12/2018
1neurabinIBA
12/2018
1ExotoxinsIBA
12/2018
1thiamine triphosphorate (TTP)IBA
01/2018
1antiarrhythmic peptide (AAP)IBA
01/2018
1Gadolinium DTPA (Magnevist)FDA Link
01/2018
1InflammasomesIBA
01/2018
1SOX Transcription FactorsIBA
11/2017
1Immunoglobulin G (IgG)IBA
11/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2017
1SurvivinIBA
12/2016
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2016
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
03/2016
1Biomarkers (Surrogate Marker)IBA
03/2016
1TensinsIBA
01/2016
1Epithelial Cell Adhesion MoleculeIBA
01/2016
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2016
1GSK-2816126IBA
11/2015
1Monoclonal AntibodiesIBA
10/2015
1Biological ProductsIBA
03/2015
1Keratins (Keratin)IBA
01/2015
1Formaldehyde (Formol)FDA Link
12/2014
1ParaffinIBA
12/2014
1RNA (Ribonucleic Acid)IBA
12/2014
1Messenger RNA (mRNA)IBA
12/2014
1trans-sodium crocetinate (crocetin)IBA
12/2014
1Mucin-1 (CA 15-3 Antigen)IBA
07/2014
1somatostatin receptor 2IBA
07/2014
1Tight Junction ProteinsIBA
01/2014
1Somatostatin Receptors (Somatostatin Receptor)IBA
10/2013
1CalciumIBA
10/2013
1Nerve Growth Factors (Neurotrophins)IBA
07/2013
1Gefitinib (Iressa)FDA Link
07/2011
1LigandsIBA
07/2011
1Tyrosine Kinase InhibitorsIBA
07/2011
1Epidermal Growth Factor (EGF)IBA
07/2011
1LeptinIBA
09/2010
1ProgesteroneFDA LinkGeneric
09/2010

Therapy/Procedure

10Therapeutics
01/2020 - 08/2006
3Radiotherapy
12/2016 - 02/2012
1Ligation
01/2018
1Aftercare (After-Treatment)
02/2012